Fermenta Biotech has informed that, in continuation to its earlier intimation dated December 7, 2025, the Board of Directors of the Company, at its meeting held today on December 10, 2025, has, considered and approved the proposal for raising of funds either by way of issuance of equity shares and/or other securities including securities convertible into equity shares, warrants or fully convertible debentures, partly convertible debentures, non-convertible debentures along with warrants, or convertible preference shares (collectively ‘Securities’), for an aggregate amount not exceeding Rs. 150 Crores, by way of public issue, rights issue, preferential allotment, private placement, including Qualified Institutions Placement(s) (‘QIP’) in one or more tranches or any other mode or combination thereof as may be permitted under applicable laws, such regulatory/statutory approvals as may be required, and subject to approval of shareholders of the Company, which will be sought separately at the appropriate time. The information required as per Listing Regulations read with SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (‘Master Circular’) is enclosed as Annexure A. The Board meeting commenced at 11:30 am (IST) and concluded at 2:50 pm (IST).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: